CN114246333A - Health-care composition with functions of resisting aging and improving immunity - Google Patents
Health-care composition with functions of resisting aging and improving immunity Download PDFInfo
- Publication number
- CN114246333A CN114246333A CN202111611960.8A CN202111611960A CN114246333A CN 114246333 A CN114246333 A CN 114246333A CN 202111611960 A CN202111611960 A CN 202111611960A CN 114246333 A CN114246333 A CN 114246333A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- astaxanthin
- lycopene
- immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000006870 function Effects 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 230000036039 immunity Effects 0.000 title claims description 23
- 230000032683 aging Effects 0.000 title claims description 18
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 claims abstract description 36
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 32
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 32
- 239000001168 astaxanthin Substances 0.000 claims abstract description 32
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 32
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 32
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 31
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 31
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 31
- 235000012661 lycopene Nutrition 0.000 claims abstract description 31
- 229960004999 lycopene Drugs 0.000 claims abstract description 31
- 239000001751 lycopene Substances 0.000 claims abstract description 31
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 31
- 102000009027 Albumins Human genes 0.000 claims abstract description 29
- 108010088751 Albumins Proteins 0.000 claims abstract description 29
- 230000036541 health Effects 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 25
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 230000036512 infertility Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- 239000010936 titanium Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 230000002035 prolonged effect Effects 0.000 abstract description 5
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 230000005779 cell damage Effects 0.000 abstract description 2
- 208000037887 cell injury Diseases 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 238000010172 mouse model Methods 0.000 description 5
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229950006238 nadide Drugs 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000011740 C57BL/6 mouse Methods 0.000 description 2
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 230000005730 ADP ribosylation Effects 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- BQOHYSXSASDCEA-KEOHHSTQSA-N Cyclic ADP-Ribose Chemical compound C([C@@H]1[C@H]([C@H]([C@@H](O1)N1C=2N=CN3C(C=2N=C1)=N)O)O)OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H]3O1 BQOHYSXSASDCEA-KEOHHSTQSA-N 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000007709 intracellular calcium signaling Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000005731 poly ADP ribosylation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the technical field of health products, and discloses a health composition with anti-aging and immunity-improving functions, which comprises a compound consisting of nicotinamide mononucleotide, albumin titanium powder, lycopene and astaxanthin, wherein the compound comprises the following raw materials in parts by weight: 3.5-4.5 parts of nicotinamide mononucleotide, 2-4 parts of albumin titanium powder, 0.5-1.5 parts of lycopene and 1.5-2.5 parts of astaxanthin, wherein the health-care composition consists of nicotinamide mononucleotide, albumin peptide powder, lycopene and astaxanthin in a certain proportion, the nicotinamide mononucleotide can restore the DNA cell damage of a human body and activate the function of the DNA cell of the human body and the astaxanthin can enhance the regeneration capability of cells, and the life of the DNA cell of the human body is prolonged, so that the life of the human body is prolonged.
Description
Technical Field
The invention relates to the technical field of health care products, in particular to a health care composition with functions of resisting aging and improving immunity.
Background
The immunity is a defense mechanism of a human body, is the capability of the human body to recognize and eliminate any foreign matters invaded from the outside, is the capability of treating aged, damaged, dead and denatured self cells and recognizing and treating in-vivo tapered and virus infected cells, modern immunology considers that the immunity is physiological reaction for recognizing and eliminating the foreign matters of the human body, an immune system is used for executing the function in the human body, the human lives in an environment which is suitable for living and full of danger for millions of years, the human can survive and obtains extraordinary immunity, so the immunity is a product in a biological evolution process, the immunity is low in epidemic force, the immune system cannot normally play a protection role, under the condition, the infection of bacteria, viruses, fungi and the like is extremely easy to cause diseases, and the disease can quickly cause the decline of the body mechanism, causing the body to show signs of aging.
Disclosure of Invention
The invention aims to provide a health-care composition with functions of resisting aging and improving immunity, so as to solve the problems in the background technology.
Technical scheme
The invention provides the following technical scheme: a health-care composition with anti-aging and immunity-improving functions comprises a compound consisting of nicotinamide mononucleotide, albumin titanium powder, lycopene and astaxanthin, wherein the compound comprises the following raw materials in parts by weight: 3.5-4.5 parts of nicotinamide mononucleotide, 2-4 parts of albumin titanium powder, 0.5-1.5 parts of lycopene and 1.5-2.5 parts of astaxanthin.
Preferably, the feed comprises the following raw materials in parts by weight: 3.5-4 parts of nicotinamide mononucleotide, 2-3 parts of albumin titanium powder, 0.5-1 part of lycopene and 1.5-2 parts of astaxanthin.
Preferably, the feed comprises the following raw materials in parts by weight: 4-4.5 parts of nicotinamide mononucleotide, 3-4 parts of albumin titanium powder, 1-1.5 parts of lycopene and 2-2.5 parts of astaxanthin.
Preferably, the purity of the nicotinamide mononucleotide, the purity of the albumin peptide powder, the purity of the lycopene and the purity of the astaxanthin are not lower than 90%.
Nicotinamide mononucleotide: nicotinamide Mononucleotide (NMN) is an important substance, the molecular weight of NMN is 334.2192, which is one of substances inherent in the human body, NMN plays an important role in energy generation of human cells, is involved in synthesis of intracellular NAD (Nicotinamide adenine dinucleotide, an important coenzyme for cellular energy conversion), plays a key role in energy metabolism of cells, and has great application value in the field of medicine, and NAD is involved in a number of important signaling pathways in mammalian cells, including poly ADP-ribosylation in DNA repair, mono ADP ribosylation in immune response and G protein-coupled signaling, and synthesis of cyclic ADP ribose and Nicotinamide adenine dinucleotide phosphate (NAADP) in intracellular calcium signaling, so Nicotinamide mononucleotide can increase the lifespan of human body.
Albumin polypeptide powder: the amino acid required by the human body is provided, which is the material basis of positive balance of the amino acid of the human body, promotes the absorption of nucleic acid in food in intestinal tracts and regulates the distribution of the nucleic acid in liver and thymus so as to improve the immune function; protecting liver, and improving liver detoxification function; the proliferation of probiotics in the intestinal tract is enhanced, and the intestinal mucosa tissue is shielded to prevent the implantation and the attack of harmful bacteria in the intestinal tract.
And (3) lycopene: the lycopene is also called as a natural antioxidant, has a color range from yellow to red, has high activity under a fat-soluble condition, has the main functions of tonifying qi and producing blood, strengthening spleen and stomach, strengthening heart and refreshing, and can also improve senile macular degeneration, wherein the higher the content of the lycopene in human plasma is, the lower the incidence rate of cancers and coronary heart diseases is. It also has anticancer and tumor inhibiting effects, and has special therapeutic effect on prostatitis.
Astaxanthin: astaxanthin is a chain-breaking antioxidant. The product has strong oxidation resistance, can remove nitrogen dioxide, sulfide, disulfide and the like, can reduce lipid peroxidation, effectively inhibit lipid peroxidation caused by free radicals, has various physiological effects of inhibiting tumorigenesis, enhancing immunity, removing free radicals in vivo and the like, has a good treatment effect on skin cancer caused by ultraviolet rays, and also has a prevention and treatment effect on eye diseases caused by diabetes.
A health-care composition with the functions of delaying sanility and improving immunity can be prepared into different dosage forms, such as oral liquid, capsule, etc.
A health composition with antiaging and immunity enhancing effects is used in preparation of health medicine or health food.
A preparation method of a health care capsule with functions of resisting aging and improving immunity comprises the following steps:
(I): selecting high-quality and pollution-free raw materials;
(II): mixing nicotinamide mononucleotide, titanium albumin powder, lycopene and astaxanthin according to a part ratio under the conditions of drying and sterility respectively, and uniformly stirring;
(III): and filling the powder after being uniformly stirred into capsules.
Advantageous effects
Compared with the prior art, the invention provides a health-care composition with anti-aging and immunity-improving functions, which has the following beneficial effects:
the health-care composition with the functions of resisting aging and improving immunity comprises nicotinamide mononucleotide, albumin peptide powder, lycopene and astaxanthin according to a certain proportion, wherein the nicotinamide mononucleotide can restore the damage of human DNA cells and activate the functions of the human DNA cells and the astaxanthin can enhance the regeneration capacity of the cells, and the service life of the human DNA cells is prolonged, so that the service life of a human body is prolonged.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
the invention provides a technical scheme that: a health capsule with anti-aging and immunity improving functions comprises a compound consisting of nicotinamide mononucleotide, albumin titanium powder, lycopene and astaxanthin, wherein the compound comprises the following raw materials in parts by weight: 3.5 parts of nicotinamide mononucleotide, 2 parts of albumin titanium powder, 0.5 part of lycopene and 1.5 parts of astaxanthin.
In this example, the purity of nicotinamide mononucleotide, the purity of albumin peptide powder, the purity of lycopene and the purity of astaxanthin are not less than 90%.
A preparation method of a health care capsule with functions of resisting aging and improving immunity comprises the following steps:
(I): selecting high-quality and pollution-free raw materials;
(II): mixing nicotinamide mononucleotide, titanium albumin powder, lycopene and astaxanthin according to a part ratio under the conditions of drying and sterility respectively, and uniformly stirring;
(III): and filling the powder after being uniformly stirred into capsules.
Example two:
the invention provides a technical scheme that: a health capsule with anti-aging and immunity improving functions comprises a compound consisting of nicotinamide mononucleotide, albumin titanium powder, lycopene and astaxanthin, wherein the compound comprises the following raw materials in parts by weight: 4 parts of nicotinamide mononucleotide, 3 parts of albumin titanium powder, 1 part of lycopene and 2 parts of astaxanthin.
In this example, the purity of nicotinamide mononucleotide, the purity of albumin peptide powder, the purity of lycopene and the purity of astaxanthin are not less than 90%.
A preparation method of a health care capsule with functions of resisting aging and improving immunity comprises the following steps:
(I): selecting high-quality and pollution-free raw materials;
(II): mixing nicotinamide mononucleotide, titanium albumin powder, lycopene and astaxanthin according to a part ratio under the conditions of drying and sterility respectively, and uniformly stirring;
(III): and filling the powder after being uniformly stirred into capsules.
Example three:
the invention provides a technical scheme of a health-care capsule with anti-aging and immunity-improving functions, which comprises a compound consisting of nicotinamide mononucleotide, albumin titanium powder, lycopene and astaxanthin, wherein the compound comprises the following raw materials in parts by weight: 4.5 parts of nicotinamide mononucleotide, 4 parts of albumin titanium powder, 1.5 parts of lycopene and 2.5 parts of astaxanthin.
In this example, the purity of nicotinamide mononucleotide, the purity of albumin peptide powder, the purity of lycopene and the purity of astaxanthin are not less than 90%.
A preparation method of a health care capsule with functions of resisting aging and improving immunity comprises the following steps:
(I): selecting high-quality and pollution-free raw materials;
(II): mixing nicotinamide mononucleotide, titanium albumin powder, lycopene and astaxanthin according to a part ratio under the conditions of drying and sterility respectively, and uniformly stirring;
(III): and filling the powder after being uniformly stirred into capsules.
Experimental data
Selecting a model: mouse model with anti-aging effect of metformin
The mouse model feed with the melbine anti-aging effect is characterized in that melbine with the mass ratio of 0.035-0.06% is added on the basis of feed raw materials for ensuring the normal growth of a mouse, C57BL/6 mice are fed freely without gastric lavage, the animal ethics are met, the reasonable dosage of melbine is controlled, the body health of the mice is ensured, the survival rate of the mice is improved, the service life of the mice is prolonged, the cataract index of the mice of 105 weeks old is remarkably reduced, and the aging is remarkably delayed. The invention also provides a preparation method of the mouse model feed, which is simple and convenient to operate, low in production cost and capable of realizing batch production. In addition, when the model feed added with 0.035% of metformin by mass ratio is fed to C57BL/6 mice to 100 weeks old, the glycosylated hemoglobin level value in the mice is lower, and the serum metabolite level related to diabetes is improved, so that the mouse model feed provided by the invention can improve the insulin sensitivity of the mice while delaying the aging of the mice, and has positive effect on preventing metabolic syndrome.
The invention selects the D-galactose to replicate the aging mouse model, the model has simple and convenient manufacturing method, obvious aging characteristics and lower experimental cost, and the model is widely applied to the research of the aging mechanism and the action mechanism of the anti-aging drug.
The experimental contents are as follows: selecting 60 male mice of the same species 90-110g, randomly dividing the mice into 5 groups (12 mice in each group), wherein the first group and the second group are not taken with the health powder, the third group, the fourth group and the fifth group are all taken with the health powder, the third group is taken with the dosage of the health powder in the first embodiment, the fourth group is taken with the dosage of the health powder in the second embodiment, the fifth group is taken with the dosage of the three health powders in the first embodiment, each group of mice is taken with the health powder once, each time each group is taken with one gram of the health powder, one week is taken with one cycle, four cycles are taken, after the taking is finished, the mice are subjected to blood drawing detection, and the blood drawing detection result is obtained as a next table;
as can be seen from the above table, the composition can restore the functions of DNA cell damage, activating DNA cells and enhancing cell regeneration, and the proportion in the fourth group (i.e., example two) is the optimal proportion.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (8)
1. A health care composition with anti-aging and immunity improving functions is characterized in that: the compound consists of nicotinamide mononucleotide, albumin titanium powder, lycopene and astaxanthin, and comprises the following raw materials in parts by weight: 3.5-4.5 parts of nicotinamide mononucleotide, 2-4 parts of albumin titanium powder, 0.5-1.5 parts of lycopene and 1.5-2.5 parts of astaxanthin.
2. The health composition with anti-aging and immunity-improving effects according to claim 2, wherein the composition comprises: comprises the following raw materials in parts by weight: 3.5-4 parts of nicotinamide mononucleotide, 2-3 parts of albumin titanium powder, 0.5-1 part of lycopene and 1.5-2 parts of astaxanthin.
3. The health composition with anti-aging and immunity-improving effects according to claim 2, wherein the composition comprises: comprises the following raw materials in parts by weight: 4-4.5 parts of nicotinamide mononucleotide, 3-4 parts of albumin titanium powder, 1-1.5 parts of lycopene and 2-2.5 parts of astaxanthin.
4. The health composition with anti-aging and immunity-improving effects according to claim 2, wherein the composition comprises: the purity of the nicotinamide mononucleotide, the purity of the albumin peptide powder, the purity of the lycopene and the purity of the astaxanthin are not lower than 90%.
5. A health care oral preparation with functions of resisting aging and improving immunity is characterized in that: comprising the compound of claim 1.
6. A health care capsule with functions of resisting aging and improving immunity is characterized in that: comprising the compound of claim 1.
7. The use of the health composition with anti-aging and immunity-enhancing effects according to claims 5 and 6 in the preparation of health drugs or health foods.
8. The method for preparing the health capsule with the functions of resisting aging and improving immunity according to claim 1, which is characterized in that: the method comprises the following steps:
(I): selecting high-quality and pollution-free raw materials;
(II): mixing nicotinamide mononucleotide, titanium albumin powder, lycopene and astaxanthin according to a part ratio under the conditions of drying and sterility respectively, and uniformly stirring;
(III): and filling the powder after being uniformly stirred into capsules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111611960.8A CN114246333A (en) | 2021-12-27 | 2021-12-27 | Health-care composition with functions of resisting aging and improving immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111611960.8A CN114246333A (en) | 2021-12-27 | 2021-12-27 | Health-care composition with functions of resisting aging and improving immunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114246333A true CN114246333A (en) | 2022-03-29 |
Family
ID=80798133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111611960.8A Withdrawn CN114246333A (en) | 2021-12-27 | 2021-12-27 | Health-care composition with functions of resisting aging and improving immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114246333A (en) |
-
2021
- 2021-12-27 CN CN202111611960.8A patent/CN114246333A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110564799A (en) | Preparation method for producing enzyme activity digestion-free protein by using soybean protein isolate as raw material | |
| CN109757733A (en) | A kind of oral polypeptide powder and its preparation method and application | |
| CN113398144B (en) | Application of nucleotide mixture in preparation of preparation for preventing or relieving sarcopenia of old people | |
| Li et al. | A novel Se-polysaccharide from Se-enriched G. frondosa protects against immunosuppression and low Se status in Se-deficient mice | |
| CN107164446A (en) | The preparation method and its antifatigue effect of deer hemepeptide | |
| CN107223981B (en) | Composition containing soybean polypeptide argatroxin and preparation method thereof | |
| CN109275681A (en) | A kind of functional food suitable for diabetes patient | |
| CN104623170A (en) | Anti-haze lung-protecting buccal tablet | |
| KR100450901B1 (en) | Preparation of Mixtures stimulating iNOS enzyme which induce immuno-reactant Nitric-Oxide Synthesis | |
| CN114246333A (en) | Health-care composition with functions of resisting aging and improving immunity | |
| CN1218690A (en) | Polypeptide oral liquor | |
| JPH07284375A (en) | Immune-enhanced food compound mainly of isaria-type 'tochu-kaso' | |
| EA030339B1 (en) | Composition comprising water soluble selenoglycoproteins and method for preparation thereof | |
| CN105963330B (en) | Miracle fruit preparation and its application | |
| CN106955290A (en) | It is a kind of to treat composition of degenerative disorders and application thereof | |
| CN108323762B (en) | Selenium-rich composition and preparation, preparation method and application thereof | |
| WO2016206363A1 (en) | Use of jilin ginseng oligopeptide in preparation of anti-oxidant food product or health care food product | |
| CN113662960A (en) | Application of selenoglucosamine in preventing and treating diabetes | |
| CN104855863A (en) | Chinese wolfberry functional food for improving body nitrogen monoxide content and preparing method thereof | |
| CN114831312B (en) | Traditional Chinese medicine composition composed of ganoderma lucidum polysaccharide and cicada fungus polysaccharide and application thereof | |
| CN115039882B (en) | Polysaccharide composition for reducing postprandial blood sugar and application thereof | |
| CN1415309A (en) | Nano selenium of Melatonin and its preparation method | |
| CN114712481B (en) | Composite plant source polypeptide and preparation method and application thereof | |
| CN114468310B (en) | Peptide composition for improving immunity and preparation method thereof | |
| CN107970437A (en) | Cordyceps sinensis gram oncogene peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220329 |